Back to results
US 5,393,784 AGranted
Treatment of tardive dyskinesia with leucine, isoleucine, valine or mixtures thereof
AssigneeNew York State Office of Mental Health
InventorMary Ann Richardson
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of remitting or attenuating the symptoms of tardive dyskinesia which can be secondary to treatment of psychiatric disorders with antipsychotic drugs, by administering leucine, isoleucine, valine or mixtures thereof.
Claims6
A method of treating tardive dyskinesia, which comprises administering to a patient having tardive dyskinesia at least one amino acid, selected from the group consisting of isoleucine, leucine and valine in an amount sufficient for treating said tardive dyskinesia.
Dependencies are inferred from the claim text.